Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM Minnesota.
Press releases published on June 24, 2025
Celebrate Innovation in Education at ISTELive 25 with zSpace
GlobeNewswire
·
June 24, 2025
SAN JOSE, Calif., June 24, 2025 (GLOBE NEWSWIRE) -- zSpace (NASDAQ: ZSPC) (“zSpace” or the “Company”), a leading provider of augmented and virtual reality solutions for education, today announced its participation in the ISTE Live 25 Conference, taking …
ClearScale Appoints Matt Stoyka as CEO, Names Jimmy Chui Chief Client Officer
GlobeNewswire
·
June 24, 2025
SAN FRANCISCO, June 24, 2025 (GLOBE NEWSWIRE) -- ClearScale, a leader in cloud modernization and an Amazon Web Services (AWS) Premier Tier Services Partner, today announced a leadership transition designed to accelerate growth and deepen client …
Plus Therapeutics Announces Comprehensive Restructuring of $15 Million March 2025 Equity Financing
GlobeNewswire
·
June 24, 2025
Comprehensive restructuring eliminates the potential issuance of up to 1.5 billion shares of common stock Plus Therapeutics files a request to withdraw the related resale registration statement with the SEC HOUSTON, June 24, 2025 (GLOBE NEWSWIRE) -- Plus …
Abeona Therapeutics® Announces Publication in The Lancet of Phase 3 VIITAL™ Study Data in Recessive Dystrophic Epidermolysis Bullosa
GlobeNewswire
·
June 24, 2025
- RDEB is a lifelong debilitating, blistering skin disease associated with large and painful wounds that often remain open for years and cause significant clinical burden, including pain, itch, and risk of squamous cell carcinoma - - ZEVASKYN™ (prademagene …
Abschließende Daten aus der realen PEARL-Studie von Teva untermauern die langfristige Wirksamkeit von AJOVY® (fremanezumab) für die Prävention chronischer und episodischer Migräne
GlobeNewswire
·
June 24, 2025
Die abschließende Analyse der realen PEARL-Studie für die Migräneprävention wurde auf dem 11. Kongress der European Academy of Neurology (EAN 2025) in Helsinki präsentiert1,2 Fremanezumab demonstrierte eine langfristige Wirksamkeit und ein günstiges …
Les données définitives de l’étude PEARL menée par Teva en conditions réelles confirment l’efficacité à long terme d’AJOVY® (frémanézumab) pour la prévention de la migraine chronique et épisodique
GlobeNewswire
·
June 24, 2025
L’analyse finale de l’étude PEARL ciblée sur la prévention de la migraine en conditions réelles a été présentée au 11ᵉ congrès de l’Académie européenne de neurologie (le congrès EAN 2025) qui s’est tenu à Helsinki1,2 Le frémanézumab a montré une efficacité …
RECORDATI ANNOUNCES EXCLUSIVE LICENSING & SUPPLY AGREEMENT WITH AMARIN TO COMMERCIALIZE VAZKEPA® IN EUROPE
GlobeNewswire
·
June 24, 2025
RECORDATI ANNOUNCES EXCLUSIVE LICENSING …
Array Technologies Announces Proposed Private Offering of $250 Million of New Convertible Senior Notes
GlobeNewswire
·
June 24, 2025
ALBUQUERQUE, N.M., June 24, 2025 (GLOBE NEWSWIRE) -- Array Technologies, Inc. (NASDAQ: ARRY) (the “Company” or “ARRAY”) today announced that, subject to market conditions, it intends to offer $250 million in aggregate principal amount of convertible senior …
Chris Pogue Joins Calian as President, Defence & Space, Powering Calian’s Next-Generation Defence and Space Capabilities
GlobeNewswire
·
June 24, 2025
OTTAWA, Ontario, June 24, 2025 (GLOBE NEWSWIRE) -- Calian Group Ltd. (TSX: CGY), a mission-critical solutions company focused on defence, space, healthcare and strategic growth critical infrastructure sectors, today announced that Chris Pogue will join the …
Microchip Enhances TrustMANAGER Platform to Support CRA Compliance and Cybersecurity Regulations
GlobeNewswire
·
June 24, 2025
CHANDLER, Ariz., June 24, 2025 (GLOBE NEWSWIRE) -- International cybersecurity regulations continue to adapt to meet the evolving threat landscape. One major focus is on outdated firmware in IoT devices, which can present significant security …
Lantronix Named the 2025 Industrial IoT Company of the Year by Leading Market Research Firm CompassIntel
GlobeNewswire
·
June 24, 2025
IRVINE, Calif., June 24, 2025 (GLOBE NEWSWIRE) -- Lantronix Inc. (NASDAQ: LTRX), a global leader of compute and connectivity for IoT solutions enabling Edge AI Intelligence, today announced that Lantronix has been named the 2025 Industrial IoT Company of …
Pando and JBF Consulting Release 2025 Report on the State of AI in Logistics
GlobeNewswire
·
June 24, 2025
CHICAGO, June 24, 2025 (GLOBE NEWSWIRE) -- Pando, a leading logistics AI company, and JBF Consulting, a leading logistics strategy advisory and technology integration firm, have released the inaugural edition of the State of AI in Logistics report. This …
Fortrea & Emery Pharma Announce Strategic Collaboration to Deliver FDA Compliant Drug-Drug-Interaction Studies Using Rifampin
GlobeNewswire
·
June 24, 2025
DURHAM, N.C., June 24, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced a strategic collaboration with Emery Pharma, a leading analytical and bioanalytical CRO providing …
Atea Pharmaceuticals Announces Continued Advancement of Global Phase 3 HCV Program with Dosing of First Patient in C-FORWARD Outside North America
GlobeNewswire
·
June 24, 2025
C-FORWARD is the Second Phase 3 Trial in the Global HCV Development Program; the First Phase 3 Trial, C-BEYOND, is Currently Enrolling Patients in the US and Canada Regimen has Potential Best-in-Class Profile with Short Treatment Duration, Low Risk for …
Amarin Announces Exclusive License and Supply Agreement with Recordati to Commercialize VAZKEPA® (Icosapent Ethyl) in Europe
GlobeNewswire
·
June 24, 2025
-- Company to Streamline Global Operations, Resulting in Approximately $70 Million of Cost Savings Over Next 12 Months and Accelerated Path to Positive Cash Flow -- -- Conference Call Today at 8:00 a.m. EDT with Investor Materials Available at …
iBio and AstralBio Unveil Obesity Program with Novel Amylin Agonist Antibody Demonstrating Promising In Vivo Results
GlobeNewswire
·
June 24, 2025
Lead amylin receptor agonist engineered antibody significantly reduced acute food intake in a mouse model of obesity, comparable to the efficacy of a leading amylin peptide agonist Findings support the potential of antibody-based agonists to address the …
Addressing Surging Demand, Vetty Reports Strong Growth, Strategic Wins and Expanded Integrations in 1H 2025
GlobeNewswire
·
June 24, 2025
AUSTIN, Texas, June 24, 2025 (GLOBE NEWSWIRE) -- Seeing a 22.4 percent increase in revenue year over year, Vetty, the one-stop shop hiring acceleration platform, has continued to build on its momentum in the first half of 2025. On pace to surpass its June …
Krystal Biotech Announces First Patient Dosed in Phase 3 Clinical Trial of KB803 for the Treatment and Prevention of Corneal Abrasions in Patients with Dystrophic Epidermolysis Bullosa
GlobeNewswire
·
June 24, 2025
Intra-patient, double-blind, multicenter, placebo-controlled study with crossover design Repeat administration under compassionate use was previously shown to be well tolerated and associated with full corneal healing by 3 months as well as significant …
Xtract One Selected to Support San Mateo Medical Center in Keeping Patients and Staff Secure
GlobeNewswire
·
June 24, 2025
TORONTO, June 24, 2025 (GLOBE NEWSWIRE) -- Xtract One Technologies (TSX: XTRA)(OTCQX: XTRAF)(FRA: 0PL) (“Xtract One” or the “Company”) today announced its SmartGateway has been selected by San Mateo Medical Center, located in San Mateo, CA, to strengthen …
Tilray Medical Receives Italy’s First Authorization from the Ministry of Health to Distribute Medical Cannabis Flower for Therapeutic Use
GlobeNewswire
·
June 24, 2025
SAVONA, Italy, June 24, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare …